nifedipine has been researched along with Hypertrophy, Left Ventricular in 60 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Hypertrophy, Left Ventricular: Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to evaluate the effects of lercanidipine or barnidipine on echocardiographic parameters, in hypertensive, type 2 diabetics with left ventricular hypertrophy." | 9.20 | Barnidipine or Lercanidipine on Echocardiographic Parameters in Hypertensive, Type 2 Diabetics with Left Ventricular Hypertrophy: A Randomized Clinical Trial. ( D'Angelo, A; Derosa, G; Franzetti, I; Maffioli, P; Mugellini, A; Pesce, RM; Querci, F, 2015) |
| "We treated with nifedipine or lisinopril 38 essential hypertensive patients with left ventricular hypertrophy." | 9.08 | Lisinopril reverses left ventricular hypertrophy through improved aortic compliance. ( Shimamoto, H; Shimamoto, Y, 1996) |
| " This study assessed the efficacy and safety of nifedipine GITS (oral release osmotic system) as monotherapy, in addition to the effects on left ventricular hypertrophy, after a long term follow-up (one year)." | 9.08 | [Nifedipine in the treatment of moderate and severe arterial hypertension. Long-term effect on arterial pressure and on the left ventricle]. ( Arocha, I; Arreaza, MR; Bustillo, N; Corral, JL; García, P; López, NC; Perozo, M, 1997) |
| "To assess the effect of 1-year treatment with rilmenidine, an oxazoline compound that exerts its antihypertensive effects through binding to imidazoline receptors in the brainstem, on left ventricular hypertrophy (LVH) secondary to essential, mild-to-moderate hypertension [supine diastolic blood pressure (DBP)95-115 mmHg]." | 9.08 | Regression of left ventricular hypertrophy in hypertensive patients after 1 year of treatment with rilmenidine: a double-blind, randomized, controlled (versus nifedipine) study. ( Balazovjech, I; Dubai, G; Dvorak, I; Januszewicz, W; Krupa-Wojciechowska, B; Kubasik, A; Kuch-Wocial, A; Polak, G; Sadowski, Z; Simon, K; Stejfa, M; Szwed, H, 1998) |
| "5 mg/day) on regression of left ventricular hypertrophy (LVH), an independent predictor of poor prognosis in hypertension, was compared by echocardiography to that of nifedipine (NFD, 40 mg/day), enalapril (ENL, 20 mg/day), atenolol (ATL, 100 mg/day), and hydrochlorothiazide (HCTZ, 25 mg/day) in four parallel double-blind studies in 151 hypertensive patients with a diastolic blood pressure between 95 and 120 mm Hg and a raised left ventricular mass index (LVMI) (mg/m2) (Devereux)." | 9.07 | Indapamide reduces hypertensive left ventricular hypertrophy: an international multicenter study. ( Amabile, G; Bory, M; De Luca, N; Denis, B; Imbs, JL; Lahiri, A; Marchegiano, R; Raftery, EB; Senior, R; Zannad, F, 1993) |
| "We investigated the regression of left ventricular (LV) hypertrophy with long-term treatment of nifedipine in patients with systemic hypertension." | 7.69 | Regression of left ventricular hypertrophy with long-term treatment of nifedipine in systemic hypertension. ( Maeda, M; Nakano, T; Oonishi, T; Teramura, S; Yamakado, T, 1994) |
| " This study evaluated the influence of aging, superimposed chronic hypertension on aging, and treatment with nifedipine on cardiac myosin isozyme proportions." | 7.68 | Alterations in cardiac myosin isozymes associated with aging and chronic hypertension: their modulation with nifedipine. ( Blomquist, TM; Minser, R; Pathak, D; Raizada, V; Woodfin, B, 1993) |
| "More enalapril-treated than nifedipine-treated patients required supplemental treatment with hydrochlorothiazide (59% versus 34%, P<0." | 6.70 | Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study evaluat ( Bella, JN; Dahlöf, B; De Quattro, V; de Simone, G; Devereux, RB; Hahn, RT; Palmieri, V; Sharpe, N; Walker, JF, 2001) |
| "Marked left ventricular hypertrophy and fibrosis were apparent and the ratio of collagen type I to type III mRNA levels and the activity of matrix metalloproteinase (MMP)-2 and its mRNA expression in the myocardium were increased in Vehicle at 19 weeks in comparison with Control." | 5.35 | Long-term administration of nifedipine attenuates cardiac remodeling and diastolic heart failure in hypertensive rats. ( Cheng, XW; Izawa, H; Kuzuya, M; Miyachi, M; Murohara, T; Nagata, K; Naruse, K; Nishizawa, T; Noda, A; Obata, K; Okumura, K; Saka, M; Yamada, T; Yokota, M, 2009) |
| "The aim of this study was to evaluate the effects of lercanidipine or barnidipine on echocardiographic parameters, in hypertensive, type 2 diabetics with left ventricular hypertrophy." | 5.20 | Barnidipine or Lercanidipine on Echocardiographic Parameters in Hypertensive, Type 2 Diabetics with Left Ventricular Hypertrophy: A Randomized Clinical Trial. ( D'Angelo, A; Derosa, G; Franzetti, I; Maffioli, P; Mugellini, A; Pesce, RM; Querci, F, 2015) |
| " Patients with essential hypertension were randomly assigned to receive either amlodipine, cilnidipine or nifedipine CR (which does not block N-type calcium channels) for 6 months." | 5.10 | Effects of calcium channel antagonists on left ventricular hypertrophy and diastolic function in patients with essential hypertension. ( Shigematsu, M; Takami, T, 2003) |
| "We treated with nifedipine or lisinopril 38 essential hypertensive patients with left ventricular hypertrophy." | 5.08 | Lisinopril reverses left ventricular hypertrophy through improved aortic compliance. ( Shimamoto, H; Shimamoto, Y, 1996) |
| " This study assessed the efficacy and safety of nifedipine GITS (oral release osmotic system) as monotherapy, in addition to the effects on left ventricular hypertrophy, after a long term follow-up (one year)." | 5.08 | [Nifedipine in the treatment of moderate and severe arterial hypertension. Long-term effect on arterial pressure and on the left ventricle]. ( Arocha, I; Arreaza, MR; Bustillo, N; Corral, JL; García, P; López, NC; Perozo, M, 1997) |
| "This study compared the effects of 1 year of monotherapy with a calcium-channel antagonist (nilvadipine; NIL), an angiotensin-converting enzyme (ACE) inhibitor (temocapril; TEM), or a new vasodilator (cadralazine; CAD) on left ventricular (LV) hypertrophy in essential hypertension." | 5.08 | The effects of long-term treatment on left ventricular hypertrophy in patients with essential hypertension: relation to changes in neurohumoral factors. ( Inoue, H; Oh-hashi, S; Takata, M; Tomita, S; Ueno, H; Yasumoto, K, 1997) |
| "To assess the effect of 1-year treatment with rilmenidine, an oxazoline compound that exerts its antihypertensive effects through binding to imidazoline receptors in the brainstem, on left ventricular hypertrophy (LVH) secondary to essential, mild-to-moderate hypertension [supine diastolic blood pressure (DBP)95-115 mmHg]." | 5.08 | Regression of left ventricular hypertrophy in hypertensive patients after 1 year of treatment with rilmenidine: a double-blind, randomized, controlled (versus nifedipine) study. ( Balazovjech, I; Dubai, G; Dvorak, I; Januszewicz, W; Krupa-Wojciechowska, B; Kubasik, A; Kuch-Wocial, A; Polak, G; Sadowski, Z; Simon, K; Stejfa, M; Szwed, H, 1998) |
| "The aim of this study was to evaluate the effect of the calcium antagonist Nifedipine GITS in a double-blind, randomized comparison with the diuretic hydrochlorothiazide (HCTZ) on reduction of left ventricular (LV) mass and minimal vascular resistance in a group of essential hypertensives with left ventricular hypertrophy (LVH)." | 5.08 | Reduction of cardiovascular structural changes by nifedipine GITS in essential hypertensive patients. ( Agabiti-Rosei, E; Corbellini, C; Monteduro, C; Muiesan, ML; Rizzoni, D; Salvetti, M; Zulli, R, 1998) |
| "5 mg/day) on regression of left ventricular hypertrophy (LVH), an independent predictor of poor prognosis in hypertension, was compared by echocardiography to that of nifedipine (NFD, 40 mg/day), enalapril (ENL, 20 mg/day), atenolol (ATL, 100 mg/day), and hydrochlorothiazide (HCTZ, 25 mg/day) in four parallel double-blind studies in 151 hypertensive patients with a diastolic blood pressure between 95 and 120 mm Hg and a raised left ventricular mass index (LVMI) (mg/m2) (Devereux)." | 5.07 | Indapamide reduces hypertensive left ventricular hypertrophy: an international multicenter study. ( Amabile, G; Bory, M; De Luca, N; Denis, B; Imbs, JL; Lahiri, A; Marchegiano, R; Raftery, EB; Senior, R; Zannad, F, 1993) |
| " We therefore investigated the effects of diltiazem on cardiac gene expression in normotensive and hypertensive rats with left ventricular hypertrophy and compared the results with our previous findings on verapamil and nifedipine." | 3.83 | Gene expression profiling of calcium-channel antagonists in the heart of hypertensive and normotensive rats reveals class specific effects. ( Borlak, J; Zwadlo, C, 2016) |
| "Losartan reduced significantly the systolic blood pressure as well as the aorta and left ventricular hypertrophy." | 3.74 | Beneficial effects of the combination of nifedipine and losartan in hypertensive Dahl salt-sensitive rats. ( Tinel, H, 2007) |
| " We treated 16-week-old rats having established LVH and myocardial fibrosis due to 8-week renovascular hypertension (RHT) with either 6 mg/kg/day zofenopril (ZOF), 30 mg/kg/day nifedipine (NIF) or 40 mg/kg/day labetalol (LAB) for 12 weeks." | 3.70 | Regression of myocardial fibrosis in hypertensive heart disease: diverse effects of various antihypertensive drugs. ( Brilla, CG, 2000) |
| "Effects of m-nifedipine (m-Nif) on the affinity and density of dihydropyridine (DHP) binding sites in the cell membranes of kidney and lung were investigated using the LVH (left ventricular hypertrophy) induced by Goldblatt (2k-1c) renovascular hypertension in elderly rats." | 3.69 | [Effects of m-nifedipine on dihydropyridine binding sites in the cell membranes of kidney and lung from left ventricular hypertrophied elderly rats]. ( Rao, MR; Xi, T; Xu, Y, 1995) |
| "We investigated the regression of left ventricular (LV) hypertrophy with long-term treatment of nifedipine in patients with systemic hypertension." | 3.69 | Regression of left ventricular hypertrophy with long-term treatment of nifedipine in systemic hypertension. ( Maeda, M; Nakano, T; Oonishi, T; Teramura, S; Yamakado, T, 1994) |
| "To evaluate the effect of acute blood pressure (BP) changes on the myocardial perfusion in hypertensives, 10 patients with and 10 patients without left ventricular hypertrophy (LVH) were examined with 99TCm-Sestamibi scintigraphy at rest and after acute pharmacological BP reduction using nifedipine and captopril." | 3.69 | Blood pressure and myocardial perfusion in hypertensive patients with and without left ventricular hypertrophy. ( Berglund, G; Boström, PA; Diemer, H; Lilja, B; Mansour, P; Mattiasson, I; Nehoum, A, 1995) |
| " This study evaluated the influence of aging, superimposed chronic hypertension on aging, and treatment with nifedipine on cardiac myosin isozyme proportions." | 3.68 | Alterations in cardiac myosin isozymes associated with aging and chronic hypertension: their modulation with nifedipine. ( Blomquist, TM; Minser, R; Pathak, D; Raizada, V; Woodfin, B, 1993) |
| "On 24 h ambulatory BP monitoring, nifedipine-GITS caused a consistent decrease in BP throughout the 24 h dosing interval, whereas felodipine-ER caused a more marked fall in BP during the day, and enalapril's effects diminished during the night and had disappeared by the morning." | 2.70 | Differential effects of once-daily antihypertensive drugs on blood pressure, left ventricular mass and sympathetic activity: Nifedipine-GITS versus felodipine-ER versus enalapril. ( Joyner, CD; Leenen, FH; Myers, MG; Toal, CB, 2002) |
| "More enalapril-treated than nifedipine-treated patients required supplemental treatment with hydrochlorothiazide (59% versus 34%, P<0." | 2.70 | Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study evaluat ( Bella, JN; Dahlöf, B; De Quattro, V; de Simone, G; Devereux, RB; Hahn, RT; Palmieri, V; Sharpe, N; Walker, JF, 2001) |
| " At the end of the dosing interval, felodipine lowered office DBP (mm Hg) by -18 +/- 12/14 +/- 1 compared to -14 +/- 2/11 +/- 1 for nifedipine (P < or = ." | 2.68 | Differential effects of felodipine and nifedipine on 24-h blood pressure and left ventricular mass. ( Leenen, FH; Myers, MG; Tanner, J, 1995) |
| "Chronic left ventricular hypertrophy (LVH) is associated with depressed contractile performance, abnormal compliance of the chamber, and ultimately, the development of a left ventricular failure." | 2.68 | [The effect of hypotensive drugs on left ventricular mass and diastolic function]. ( Haczyński, J; Jołda-Mydłowska, B; Spring, A; Witkowska, M, 1995) |
| "Hypertension affects about 5% of western populations and in the majority of cases it is of unknown aetiology." | 2.41 | Experimental studies on myocardial stretch and ventricular arrhythmia in hypertrophied and non-hypertrophied hearts. ( Dalton, GR; Evans, SJ; Levi, AJ, 2000) |
| "Marked left ventricular hypertrophy and fibrosis were apparent and the ratio of collagen type I to type III mRNA levels and the activity of matrix metalloproteinase (MMP)-2 and its mRNA expression in the myocardium were increased in Vehicle at 19 weeks in comparison with Control." | 1.35 | Long-term administration of nifedipine attenuates cardiac remodeling and diastolic heart failure in hypertensive rats. ( Cheng, XW; Izawa, H; Kuzuya, M; Miyachi, M; Murohara, T; Nagata, K; Naruse, K; Nishizawa, T; Noda, A; Obata, K; Okumura, K; Saka, M; Yamada, T; Yokota, M, 2009) |
| "Nifedipine-treated animals displayed hemodynamics, LV dilatation, hypertrophy, and loss of function similar to those of the untreated group." | 1.35 | Comparative study of vasodilators in an animal model of chronic volume overload caused by severe aortic regurgitation. ( Arsenault, M; Beaudoin, J; Champetier, S; Couet, J; Lachance, D; Plante, E; Roussel, E, 2009) |
| "Renovascular hypertension was produced by clipping the left renal artery in 20-month-old rats." | 1.29 | Effects of menidipine on dihydropyridines binding sites in cardiac and cerebral membranes from old rats with left ventricular hypertrophy. ( Rao, MR; Xi, T, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 34 (56.67) | 18.2507 |
| 2000's | 22 (36.67) | 29.6817 |
| 2010's | 4 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zimmer, J | 1 |
| Hawlitschek, C | 1 |
| Rabald, S | 1 |
| Hagendorff, A | 1 |
| Zimmer, HG | 1 |
| Rassler, B | 1 |
| Derosa, G | 1 |
| Mugellini, A | 1 |
| Querci, F | 1 |
| Franzetti, I | 1 |
| Pesce, RM | 1 |
| D'Angelo, A | 1 |
| Maffioli, P | 1 |
| Zwadlo, C | 1 |
| Borlak, J | 1 |
| Yamada, T | 1 |
| Nagata, K | 1 |
| Cheng, XW | 1 |
| Obata, K | 1 |
| Saka, M | 1 |
| Miyachi, M | 1 |
| Naruse, K | 1 |
| Nishizawa, T | 1 |
| Noda, A | 1 |
| Izawa, H | 1 |
| Kuzuya, M | 1 |
| Okumura, K | 1 |
| Murohara, T | 1 |
| Yokota, M | 1 |
| Ye, P | 1 |
| Wu, CE | 1 |
| Sheng, L | 1 |
| Li, H | 1 |
| Plante, E | 2 |
| Lachance, D | 1 |
| Beaudoin, J | 1 |
| Champetier, S | 1 |
| Roussel, E | 1 |
| Arsenault, M | 2 |
| Couet, J | 2 |
| Bozbaş, SS | 1 |
| Bozbaş, H | 1 |
| Atar, A | 1 |
| Ulubay, G | 1 |
| Oner Eyüboğlu, F | 1 |
| Leenen, FH | 2 |
| Myers, MG | 2 |
| Joyner, CD | 1 |
| Toal, CB | 1 |
| Tse, HF | 1 |
| Cheung, BM | 1 |
| Ng, W | 1 |
| Chan, JK | 1 |
| Devereux, RB | 4 |
| Lau, CP | 1 |
| Gaudreau, M | 1 |
| Dumas, MP | 1 |
| Drolet, MC | 1 |
| Terpstra, WF | 1 |
| May, JF | 1 |
| Smit, AJ | 1 |
| de Graeff, PA | 1 |
| Crijns, HJ | 1 |
| Takami, T | 1 |
| Shigematsu, M | 1 |
| Boydak, B | 1 |
| Nalbantgil, S | 1 |
| Yilmaz, H | 1 |
| Zoghi, M | 1 |
| Ozerkan, F | 1 |
| Nalbantgil, I | 1 |
| Onder, R | 1 |
| Higashikuni, Y | 1 |
| Sata, M | 1 |
| Nagai, R | 1 |
| Iskenderov, BG | 2 |
| Burmistrova, LF | 2 |
| Vakina, TN | 1 |
| Lokhina, TV | 2 |
| Bogdanova, SR | 1 |
| Afshinnia, F | 1 |
| Xie, HH | 1 |
| Shen, FM | 1 |
| Zhang, XF | 1 |
| Jiang, YY | 1 |
| Su, DF | 1 |
| Tinel, H | 1 |
| Berenshteĭn, NV | 1 |
| Senior, R | 1 |
| Imbs, JL | 1 |
| Bory, M | 1 |
| Amabile, G | 1 |
| Denis, B | 1 |
| Zannad, F | 1 |
| De Luca, N | 1 |
| Marchegiano, R | 1 |
| Lahiri, A | 1 |
| Raftery, EB | 1 |
| Tanner, J | 1 |
| Li, QP | 1 |
| Rao, MR | 8 |
| Xu, Y | 2 |
| Xi, T | 5 |
| Phillips, RA | 2 |
| Ghali, JK | 1 |
| Kirpizidis, HG | 1 |
| Papazachariou, GS | 1 |
| Yamakado, T | 1 |
| Teramura, S | 1 |
| Oonishi, T | 1 |
| Maeda, M | 1 |
| Nakano, T | 1 |
| Yang, JR | 1 |
| Wu, DM | 1 |
| Habib, GB | 1 |
| Mann, DL | 1 |
| Zoghbi, WA | 1 |
| Nishimura, H | 2 |
| Kubota, J | 1 |
| Okabe, M | 2 |
| Ueyama, M | 1 |
| Oka, T | 1 |
| Kawamura, K | 2 |
| Savchenko, AP | 1 |
| Smirnov, AA | 1 |
| Bekzhigitov, SB | 1 |
| Abugov, SA | 1 |
| Shapkina, LS | 1 |
| Arabidze, GG | 1 |
| Raizada, V | 1 |
| Pathak, D | 1 |
| Blomquist, TM | 1 |
| Minser, R | 1 |
| Woodfin, B | 1 |
| Amici, E | 1 |
| Patruno, N | 1 |
| Natale, E | 1 |
| Marsocci, A | 1 |
| Gambelli, G | 1 |
| Sau, F | 1 |
| Seguro, C | 1 |
| Lai, C | 1 |
| Onnis, E | 1 |
| Orani, E | 1 |
| Soro, A | 1 |
| Leo, MR | 1 |
| Cherchi, A | 1 |
| Spring, A | 1 |
| Haczyński, J | 1 |
| Jołda-Mydłowska, B | 1 |
| Witkowska, M | 1 |
| Dahlof, B | 2 |
| Levy, D | 1 |
| Pfeffer, MA | 1 |
| Boström, PA | 1 |
| Mansour, P | 1 |
| Diemer, H | 1 |
| Mattiasson, I | 1 |
| Nehoum, A | 1 |
| Lilja, B | 1 |
| Berglund, G | 1 |
| Shimamoto, H | 1 |
| Shimamoto, Y | 1 |
| Handa, S | 1 |
| Hamada, M | 1 |
| Ura, M | 1 |
| Yoshida, S | 1 |
| Nishio, I | 1 |
| López, NC | 1 |
| Corral, JL | 1 |
| Perozo, M | 1 |
| García, P | 1 |
| Bustillo, N | 1 |
| Arreaza, MR | 1 |
| Arocha, I | 1 |
| Ueno, H | 1 |
| Takata, M | 1 |
| Tomita, S | 1 |
| Oh-hashi, S | 1 |
| Yasumoto, K | 1 |
| Inoue, H | 1 |
| Donohue, TJ | 1 |
| Dworkin, LD | 1 |
| Ma, J | 1 |
| Lango, MN | 1 |
| Catanese, VM | 1 |
| Kimpara, T | 1 |
| Hayashi, T | 1 |
| Imamura, K | 1 |
| Chang, KC | 1 |
| Cherng, WJ | 1 |
| Sadowski, Z | 1 |
| Szwed, H | 1 |
| Kuch-Wocial, A | 1 |
| Kubasik, A | 1 |
| Januszewicz, W | 1 |
| Krupa-Wojciechowska, B | 1 |
| Polak, G | 1 |
| Stejfa, M | 1 |
| Dvorak, I | 1 |
| Balazovjech, I | 1 |
| Dubai, G | 1 |
| Simon, K | 1 |
| Agabiti-Rosei, E | 1 |
| Zulli, R | 1 |
| Muiesan, ML | 1 |
| Salvetti, M | 1 |
| Rizzoni, D | 1 |
| Corbellini, C | 1 |
| Monteduro, C | 1 |
| Wei, AY | 1 |
| Li, YQ | 1 |
| Chen, JF | 1 |
| Liu, M | 1 |
| Ji, Y | 1 |
| Brilla, CG | 1 |
| Evans, SJ | 1 |
| Dalton, GR | 1 |
| Levi, AJ | 1 |
| Schussheim, AE | 1 |
| Diamond, JA | 1 |
| Sareli, P | 2 |
| Radevski, IV | 1 |
| Valtchanova, ZP | 1 |
| Libhaber, E | 2 |
| Candy, GP | 1 |
| Den Hond, E | 1 |
| Libhaber, C | 1 |
| Skudicky, D | 2 |
| Wang, JG | 2 |
| Staessen, JA | 2 |
| Palmieri, V | 2 |
| Sharpe, N | 1 |
| De Quattro, V | 1 |
| Bella, JN | 1 |
| de Simone, G | 1 |
| Walker, JF | 1 |
| Hahn, RT | 1 |
| Candy, G | 1 |
| Radevski, I | 1 |
| Valtchanova, Z | 1 |
| Tshele, E | 1 |
| Thijs, L | 1 |
| Gosse, P | 1 |
| Roudaut, R | 1 |
| Dallocchio, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of Some Emerging Biomarkers of Cardiovascular Risk Stratification in Hypertensive Patients: a 5-years Follow-up[NCT02064218] | 0 participants | Observational | 2007-11-30 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for nifedipine and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Etiology, pathophysiology, and treatment of left ventricular hypertrophy: focus on severe hypertension.
Topics: Administration, Oral; Blood Pressure; Delayed-Action Preparations; Drug Delivery Systems; Female; Hu | 1993 |
Experimental studies on myocardial stretch and ventricular arrhythmia in hypertrophied and non-hypertrophied hearts.
Topics: Animals; Arrhythmias, Cardiac; Calcium; Calcium Channel Blockers; Cardiotonic Agents; Death, Sudden, | 2000 |
Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Atenolol; Calcium Channe | 2002 |
26 trials available for nifedipine and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Barnidipine or Lercanidipine on Echocardiographic Parameters in Hypertensive, Type 2 Diabetics with Left Ventricular Hypertrophy: A Randomized Clinical Trial.
Topics: Aged; Antihypertensive Agents; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Dihydropyridines | 2015 |
Potential protective effect of long-term therapy with Xuezhikang on left ventricular diastolic function in patients with essential hypertension.
Topics: Aged; Biological Products; Blood Flow Velocity; C-Reactive Protein; Calcium Channel Blockers; Case-C | 2009 |
Comparative effects of losartan and nifedipine therapy on exercise capacity, Doppler echocardiographic parameters and endothelin levels in patients with secondary pulmonary hypertension.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Diastol | 2010 |
Differential effects of once-daily antihypertensive drugs on blood pressure, left ventricular mass and sympathetic activity: Nifedipine-GITS versus felodipine-ER versus enalapril.
Topics: Antihypertensive Agents; Biomarkers; Blood Pressure; Data Interpretation, Statistical; Enalapril; Fe | 2002 |
Regression of left ventricular hypertrophy after treatment of hypertension: comparison of directed M-echocardiography with magnetic resonance imaging in quantification of serial mass changes.
Topics: Aged; Antihypertensive Agents; Calcium Channel Blockers; Echocardiography; Enalapril; Female; Humans | 2003 |
Effects of nifedipine on carotid and femoral arterial wall thickness in previously untreated hypertensive patients.
Topics: Adult; Blood Pressure; Calcium Channel Blockers; Carotid Arteries; Cholesterol; Echocardiography; Fe | 2003 |
Effects of calcium channel antagonists on left ventricular hypertrophy and diastolic function in patients with essential hypertension.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diastole; Dihydropyri | 2003 |
The effect of combination therapy on regression of left ventricular hypertrophy in cases with hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Ch | 2004 |
[Hypotensive efficacy and tolerability of combination of dihydropyridine and non-dihydropyridine calcium antagonists in the treatment of patients with arterial hypertension].
Topics: Adult; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Dihydropyridines; Dose-Response Relation | 2007 |
Indapamide reduces hypertensive left ventricular hypertrophy: an international multicenter study.
Topics: Adult; Aged; Atenolol; Blood Pressure; Double-Blind Method; Enalapril; Female; France; Humans; Hydro | 1993 |
Differential effects of felodipine and nifedipine on 24-h blood pressure and left ventricular mass.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, | 1995 |
Comparative effects of fosinopril and nifedipine on regression of left ventricular hypertrophy in hypertensive patients: a double-blind study.
Topics: Blood Pressure; Blood Pressure Determination; Double-Blind Method; Drug Therapy, Combination; Echoca | 1995 |
Normalization of cardiac structure and function after regression of cardiac hypertrophy.
Topics: Adult; Case-Control Studies; Heart Ventricles; Hemodynamics; Humans; Hypertension; Hypertrophy, Left | 1994 |
[The effect of nifedipine in hypertensive cardiopathy. An echocardiographic and electrocardiographic study].
Topics: Adult; Analysis of Variance; Echocardiography; Electrocardiography; Female; Hemodynamics; Humans; Hy | 1993 |
[The effect of hypotensive drugs on left ventricular mass and diastolic function].
Topics: Adult; Aged; Antihypertensive Agents; Calcium Channel Blockers; Diastole; Drug Therapy, Combination; | 1995 |
Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial).
Topics: Antihypertensive Agents; Double-Blind Method; Echocardiography; Enalapril; Female; Follow-Up Studies | 1996 |
Lisinopril reverses left ventricular hypertrophy through improved aortic compliance.
Topics: Aged; Antihypertensive Agents; Aorta; Compliance; Cross-Over Studies; Echocardiography; Female; Hear | 1996 |
[Nifedipine in the treatment of moderate and severe arterial hypertension. Long-term effect on arterial pressure and on the left ventricle].
Topics: Adult; Aged; Calcium Channel Blockers; Dose-Response Relationship, Drug; Female; Humans; Hypertensio | 1997 |
The effects of long-term treatment on left ventricular hypertrophy in patients with essential hypertension: relation to changes in neurohumoral factors.
Topics: Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atrial | 1997 |
Regression of left ventricular hypertrophy in hypertensive patients after 1 year of treatment with rilmenidine: a double-blind, randomized, controlled (versus nifedipine) study.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diastole; Double-Blind Met | 1998 |
Reduction of cardiovascular structural changes by nifedipine GITS in essential hypertensive patients.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Delayed-Action Prepa | 1998 |
[Clinical study on combined treatment of shuizhi tuyuan powder and nifedipine in treating hypertension patients complicated with left ventricular hypertrophy].
Topics: Adult; Aged; Animals; Calcium Channel Blockers; Drug Therapy, Combination; Female; Humans; Hypertens | 1996 |
Efficacy of different drug classes used to initiate antihypertensive treatment in black subjects: results of a randomized trial in Johannesburg, South Africa.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Black Pe | 2001 |
Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study evaluat
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Diastole; | 2001 |
Relationship between treatment-induced changes in left ventricular mass and blood pressure in black african hypertensive patients: results of the Baragwanath Trial.
Topics: Angiotensin-Converting Enzyme Inhibitors; Black People; Blood Pressure; Body Mass Index; Calcium Cha | 2002 |
[Effects of verapamil and nifedipine on blood pressure during rest and exertion and on left ventricular hypertrophy].
Topics: Adult; Aged; Blood Pressure; Double-Blind Method; Echocardiography, Doppler; Exercise Test; Female; | 1992 |
31 other studies available for nifedipine and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Effects of late-onset and long-term captopril and nifedipine treatment in aged spontaneously hypertensive rats: Echocardiographic studies.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Captopril; Drug Evaluati | 2015 |
Gene expression profiling of calcium-channel antagonists in the heart of hypertensive and normotensive rats reveals class specific effects.
Topics: Animals; Calcium Channel Blockers; Diltiazem; Gene Expression Profiling; Gene Expression Regulation; | 2016 |
Long-term administration of nifedipine attenuates cardiac remodeling and diastolic heart failure in hypertensive rats.
Topics: Animals; Antihypertensive Agents; Calcium Channel Blockers; Collagen; Disease Models, Animal; Fibros | 2009 |
Comparative study of vasodilators in an animal model of chronic volume overload caused by severe aortic regurgitation.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic V | 2009 |
Left ventricular response to sustained volume overload from chronic aortic valve regurgitation in rats.
Topics: Animals; Aortic Valve Insufficiency; Calcium Channel Blockers; Echocardiography; Hypertrophy, Left V | 2003 |
Reversible left ventricular hypertrophy after tako-tsubo-like cardiomyopathy.
Topics: Aged; Aspirin; Benzimidazoles; Biphenyl Compounds; Cardiomyopathy, Dilated; Chest Pain; Drug Therapy | 2005 |
[Efficacy of and tolerance to combined therapy with dihydropyridine and non-dihydropyridine Ca antagonists in patients with moderate arterial hypertension].
Topics: Adult; Aged; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Dose-R | 2005 |
Vasodilators in aortic regurgitation.
Topics: Aortic Valve Insufficiency; Enalapril; Humans; Hypertrophy, Left Ventricular; Nifedipine; Vasodilato | 2006 |
Blood pressure variability, baroreflex sensitivity and organ damage in spontaneously hypertensive rats treated with various antihypertensive drugs.
Topics: Animals; Antihypertensive Agents; Aorta; Atenolol; Baroreflex; Biphenyl Compounds; Blood Pressure; C | 2006 |
Beneficial effects of the combination of nifedipine and losartan in hypertensive Dahl salt-sensitive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Blood Pressure; Calcium Channel Blockers; D | 2007 |
[Effects of calcium antagonists on withdrawal of beta-receptor blockers in rats during left ventricular hypertrophy].
Topics: Animals; Hemodynamics; Hypertrophy, Left Ventricular; Isomerism; Male; Metoprolol; Myocardium; Nifed | 1995 |
[Effects of m-nifedipine on dihydropyridine binding sites in the cell membranes of kidney and lung from left ventricular hypertrophied elderly rats].
Topics: Animals; Calcium Channels; Calcium Channels, L-Type; Cell Membrane; Hypertension, Renovascular; Hype | 1995 |
[Effects of m-nifedipine on left ventricular diastolic function and Ca2+ content of myocardial and cerebral mitochondria and artery tissues in left ventricular hypertrophied rats].
Topics: Animals; Aorta; Brain; Calcium; Diastole; Hypertension, Renovascular; Hypertrophy, Left Ventricular; | 1995 |
Effect of nifedipine on pulmonary hemodynamics.
Topics: Blood Pressure; Hemodynamics; Humans; Hypertension, Pulmonary; Hypertrophy, Left Ventricular; Nifedi | 1995 |
Regression of left ventricular hypertrophy with long-term treatment of nifedipine in systemic hypertension.
Topics: Adult; Aged; Blood Pressure; Echocardiography; Female; Heart Rate; Humans; Hypertension; Hypertrophy | 1994 |
[Effects of m-nifedipine and nifedipine on hemodynamics in renovascular hypertensive rats].
Topics: Animals; Blood Pressure; Hemodynamics; Hypertension, Renovascular; Hypertrophy, Left Ventricular; In | 1994 |
Effects of m-nifedipine on dihydropyridine binding sites in cardiac and cerebral cortex cell membranes from left ventricular hypertrophied rats.
Topics: Animals; Binding Sites; Calcium Channels, L-Type; Cerebral Cortex; Dihydropyridines; Hypertension, R | 1993 |
Left ventricular function of the heart regressed by nifedipine in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Hemodynamics; Hypertension; Hypertrophy, Left Ventricular; Male; Nifedipine | 1994 |
[Left ventricular function in patients with arterial hypertension during the performance of acute drug tests with captopril and nifedipine].
Topics: Adult; Captopril; Drug Evaluation; Heart Function Tests; Humans; Hypertension; Hypertrophy, Left Ven | 1993 |
Alterations in cardiac myosin isozymes associated with aging and chronic hypertension: their modulation with nifedipine.
Topics: Aging; Animals; Chronic Disease; Electrophoresis, Polyacrylamide Gel; Hypertension; Hypertrophy, Lef | 1993 |
[A reduction of left ventricular hypertrophy and an improvement in diastolic function after therapy with nifedipine retard in patients with hypertensive cardiopathy].
Topics: Adult; Aged; Delayed-Action Preparations; Diastole; Drug Evaluation; Echocardiography; Echocardiogra | 1993 |
Blood pressure and myocardial perfusion in hypertensive patients with and without left ventricular hypertrophy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Captopril; Coron | 1995 |
Regression of increased left ventricular masses in elderly hypertensive patients on lisinopril as assessed by magnetic resonance imaging.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; | 1996 |
Effects of m-nifedipine on dihydropyridine binding sites in hypertrophied left ventricular cell membranes from deoxycorticosterone acetate-salt hypertensive rats.
Topics: Animals; Binding Sites; Calcium; Calcium Channel Blockers; Desoxycorticosterone; Dihydropyridines; H | 1996 |
Antihypertensive agents that limit ventricular hypertrophy inhibit cardiac expression of insulin-like growth factor-I.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Enalapril; Heart; Hydralazine; Hypertension; Hyper | 1997 |
Ultrastructural changes during myocardial hypertrophy and its regression: long-term effects of nifedipine in adult spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Capillaries; Cell Size; Heart Ventricles; Hypertension; Hypertrophy, Left V | 1997 |
Once-daily nifedipine sustained release (nifelan) on forearm vascular resistance and regression of left ventricular hypertrophy in patients with mild to moderate essential hypertension.
Topics: Adult; Aged; Calcium Channel Blockers; Female; Forearm; Hemodynamics; Humans; Hypertension; Hypertro | 1998 |
Effects of menidipine on dihydropyridines binding sites in cardiac and cerebral membranes from old rats with left ventricular hypertrophy.
Topics: Animals; Brain; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Cell Membrane; | 1996 |
[Effects of m-Nif and Nif on left ventricle hypertrophy in rats induced by partial ligation of abdominal aorta].
Topics: Animals; Aorta, Abdominal; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Hyp | 1996 |
Regression of myocardial fibrosis in hypertensive heart disease: diverse effects of various antihypertensive drugs.
Topics: Animals; Antihypertensive Agents; Captopril; Collagen; Fibrosis; Hypertension, Renovascular; Hypertr | 2000 |
Left ventricular midwall function improves with antihypertensive therapy and regression of left ventricular hypertrophy in patients with asymptomatic hypertension.
Topics: Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Echocardiogr | 2001 |